logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO-GU 2020 — Clear cell RCC: novel drug holds promise for advanced cases

The drug is an oral hypoxia-inducible factor 2-alpha inhibitor.